BRIEF published on 11/21/2025 at 03:20, 9 months 20 days ago Appulse Corporation annonce ses résultats financiers pour les neuf mois clos le 30 septembre 2025 Résultats Financiers Options D'achat D'actions Opportunités D'investissement Perte Nette Appulse Corporation
BRIEF published on 11/21/2025 at 01:35, 9 months 20 days ago Onco-Innovations Advances PNKP Inhibitor Scale-Up with Dalton Partnership Cancer Treatment Clinical Studies Dalton Pharma Services PNKP Inhibitor Manufacturing Optimization
BRIEF published on 11/21/2025 at 01:35, 9 months 20 days ago Onco-Innovations accélère la production d'inhibiteurs de PNKP grâce à un partenariat avec Dalton. Traitement Du Cancer Études Cliniques Optimisation De La Production Services Pharmaceutiques Dalton Inhibiteur De PNKP
BRIEF published on 11/21/2025 at 00:05, 9 months 20 days ago Poxel Announces Upcoming General Meeting and Document Access General Meeting Electronic Voting Voting Procedures Poxel SA Shareholder Access
BRIEF published on 11/21/2025 at 00:05, 9 months 20 days ago Poxel annonce sa prochaine assemblée générale et l'accès aux documents Assemblée Générale Vote Électronique Procédures De Vote Poxel SA Accès Des Actionnaires
BRIEF published on 11/20/2025 at 23:40, 9 months 20 days ago Barton Gold Presents at Swiss Mining Institute Conference Gold Production Mineral Resources Barton Gold South Australia Swiss Mining Institute
BRIEF published on 11/20/2025 at 23:40, 9 months 20 days ago Barton Gold présente ses travaux à la conférence de l'Institut suisse des mines Ressources Minérales Production D'or Barton Gold Australie Du Sud Institut Suisse Des Mines
BRIEF published on 11/20/2025 at 23:35, 9 months 20 days ago EQ Inc. Announces Growth in Third Quarter Financial Results Financial Results Revenue Growth Data-driven Solutions EQ Inc. Paymi Division
BRIEF published on 11/20/2025 at 23:35, 9 months 20 days ago EQ Inc. annonce une croissance de ses résultats financiers au troisième trimestre Résultats Financiers Croissance Des Revenus Solutions Basées Sur Les Données EQ Inc. Division Paymi
BRIEF published on 11/20/2025 at 23:10, 9 months 20 days ago Caldwell Partners Announces Strong Q4 Results and Dividend Increase Financial Results Revenue Growth Operational Efficiency Shareholder Value Dividend Increase
Published on 09/11/2026 at 17:00, 1 hour 17 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 1 hour 17 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 2 hours 52 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 3 hours 17 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 3 hours 47 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:00, 17 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 17 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 17 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 11 hours 17 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 11 hours 17 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 11 hours 17 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 11 hours 17 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 22 hours 47 minutes ago Availability of the 2026 Interim Financial Report
